Discrimination between live and apoptotic cells is important for accurate determination of viable CD34 þ cells in hematopoietic stem cell transplant products. SYTO16 is a sensitive fluorescent dye for discriminating live from apoptotic leukocytes. The incidence of apoptotic leukocytes in paired samples of fresh and cryopreservedthawed cord blood (CB) was determined by the SYTO16/7-AAD flow cytometric assay. Cell migration and expression of the cell homing molecule L-selectin (CD62L) was determined in relation to SYTO16 staining. SYTO16 detected significant proportions of apoptotic lymphocytes and CD34 þ cells in fresh and thawed CB buffy-coat samples that were not detected by 7-AAD. Compared to fresh CB, the proportion of apoptotic lymphocytes and CD34 þ cells significantly increased following thawing. Significantly higher proportions of live SYTO16 bright lymphocytes and CD34 þ cells were found in the migrated cell population compared to the nonmigrated population. Significantly fewer lymphocytes and CD34 þ cells expressed CD62L following thawing. Absence of CD62L expression was strongly correlated with apoptotic/SYTO16 dim lymphocytes and CD34 þ cells. Cryopreserved-thawed CB contains significant proportions of apoptotic lymphocytes and CD34 þ cells that are not detected by 7-AAD. SYTO16 offers a sensitive method for discrimination of live from apoptotic leukocytes and assists in accurate assessment of CB quality and suitability for use in clinical transplantation.
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Introduction
Human umbilical cord blood (CB) is now an accepted alternative source of hematopoietic stem cells (HSCs) for unrelated donor allogeneic transplantation in children and adults. 1,2 A significant obstacle to the wider use of CB, particularly for adult patients, is the concern of limited graft cell dose. Engraftment and survival data have indicated that the infused nucleated cell dose and infused CD34 þ cell dose (in addition to the extent of HLA disparity) are important predictors of the outcome of CB transplantation.
1,2 Therefore, accurate assessment of CB products for cellular content and cell viability is critical for determining the suitability of these products for transplantation.
Cell impermeant dyes that stain dead cells, such as Trypan blue, propidium iodide or 7-amino-actinomycin-D (7-AAD), are commonly used to determine cell viability in HSC transplant products, including CB. Such dyes do not distinguish apoptotic cells from viable cells. We and others have shown that the vital fluorescence dye SYTO s 16 (Molecular Probes, Eugene, OR, USA) is a sensitive discriminator of live, apoptotic and necrotic leukocytes and detects apoptotic leukocytes ahead of annexin-V binding. 3, 4 Changes in the fluorescence intensity of the SYTO 16 dye correlate with the viability status of the cell in that live cells are seen as brightly fluorescent, while apoptotic cells show dimmer fluorescence intensity that diminishes further with progression to terminal stages of cell death. Cell viability assessment by SYTO 3, 6 These findings suggest that viability estimations that use conventional cell impermeant dyes, such as 7-AAD, may significantly over-estimate the viable CD34 þ cell dose in cryopreserved PBSC products. 5 To our knowledge comparable studies have not been reported for cryopreserved CB.
Other effects of cryopreservation on CD34 þ cells include reduced expression of cell adhesion/homing molecules, such as L-selectin (CD62L). [7] [8] [9] [10] [11] Reduced CD62L expression has been associated with lower in vitro migration function of thawed CD34 þ cells. 9 Coexpression of CD62L on CB CD34 þ cells has been shown to correlate with clonogenic capacity, 12 and with the time to recovery of peripheral blood neutrophil and/or platelet counts following HSC transplant. 13, 14 These findings suggest that CD62L plays an important role in HSC engraftment. The relationship of cell viability and expression of cell adhesion molecules, such as CD62L on cryopreserved CD34 þ cells has not been reported.
In the present study, paired fresh and cryopreserved CB samples and the SYTO 16/7-AAD assay 4 were used to investigate the effect of cryopreservation on the viability of CD34 þ cells and lymphocytes, and the relationship of cell viability, chemotactic response and CD62L expression. To mimic the characteristics of banked CB units, procedures were used that replicated as closely as possible those used by Cord Blood Banks. 15 A paired sample design of fresh and cryopreserved CB samples was used to minimize confounding effects of variables inherently associated with CB donors and CB collection.
Materials and methods
CB collection and processing CB was obtained from the BMDI Cord Blood BankMelbourne and was collected from normal full-term deliveries with informed consent from the mothers and institutional ethics committee approval. Only units not acceptable for banking were used in this study (usually due to low total nucleated cell count or maternal factors). Briefly, CB was collected into blood collection bags containing 35 ml CPD anti-coagulant (Fenwal, Baxter Healthcare, Morelos, Mexico). The leukocyte-rich buffy coat (BC) fraction was obtained following centrifugation of the CB unit. An aliquot of the fresh CB-BC sample was used for cell counts and staining analysis, and the remainder of the sample was cryopreserved (see below). Prior to analysis, red blood cells (RBCs) in the fresh CB-BC aliquot were lysed with warm bicarbonate-buffered ammonium chloride solution (0.15 M NH 4 Cl, 0.01 M NaHCO 3 , 1.0 mM EDTA) for 10 min at 371C. Cells were centrifuged and resuspended to 1 Â 10 7 live nucleated cells/ml in phenol red-free DMEM (Gibco, Grand Island, NY, USA). The nucleated cell viability of fresh CB-BC samples was 495%, determined by Trypan blue staining. CB units (n ¼ 24) used in this study had a mean net CB volume of 5477 ml (range 42-90 ml) and mean total nucleated cell count of 7.671.7 Â 10 8 (range, 3-13 Â 10 8
). Mean elapsed time from CB collection to cryopreservation was 2579 h (range, 7-50 h).
CB cryopreservation and thawing CB-BC was cryopreserved by adding an equal volume of ice-cold cryopreserving solution that consisted of 20% (v/v) dimethylsulfoxide (DMSO) (Cryoserv; Research Industries, Salt Lake City, UT, USA), 20% (v/v) serum, 60% (v/v) of 10% (w/v) dextran/saline solution (Dextran 40; Baxter) (i.e. final concentrations, 10% DMSO, 10% serum and 3% dextran). The cell mixture was cryopreserved in cryovials (Nunc, Roskilde, Denmark) at a freezing rate of approximately 11C/min and the frozen vials were transferred to liquid nitrogen storage.
Cryopreserved CB-BC samples were thawed quickly in a 371C waterbath and then slowly diluted with an equal volume of an ice-cold solution of 2.5% human serum albumin (HSA) (CSL, Melbourne, Australia) in 10% dextran-saline (Baxter), containing DNase I (25 U/ml; Sigma Chemicals, St Louis, MI, USA) to minimize cell clumping. 16 After 10 min, the thawed cells were further diluted to a final 1:10 dilution, centrifuged and resuspended in phenol red-free Dulbecco's Modified Eagles Medium (DMEM; Gibco, Grand Island, NY, USA) supplemented with 25 U/ml DNase I. Thawed CB-BC samples were not subjected to RBC lysis treatment. Nucleated cell counts were determined by manual counting and cell viability by Trypan blue staining. The cell suspension was adjusted to 1 Â 10 7 live nucleated cells/ml and the SYTO 16/7-AAD assay was performed without delay.
Cell staining and flow cytometry Briefly, 1 Â 10 6 CB nucleated cells were stained with 4 nM SYTO 16 in the presence of 30 mM verapamil (Sigma) in a total volume of 0.5 ml for 45 min at 371C as previously described. 4 SYTO 16 concentration, cell concentration and incubation time are inter-related, thus alteration of any of these parameters will influence the brightness of the stained cells, particularly given the sub-saturating concentration of SYTO 16 essential for discrimination of live and apoptotic leukocytes. 4 After one wash with 2 ml phosphate-buffered saline/0.5% bovine serum albumin, the supernatant was decanted and the cells were resuspended in the residual supernatant followed by incubation with pre-determined optimal concentrations of fluorochrome-conjugated monoclonal antibodies (CD34 (clone 581)-phycoerythrin (PE), CD45 (clone J.33)-phycoerythrin-cyanin 7 (PC7) and CD62L (clone DREG56)-phycoerythrin-Texas Red-X (ECD) or appropriate fluorochrome-conjugated isotype controls (Beckman Coulter, Fullerton, CA, USA)) for 10 min at room temperature. The volume was adjusted to 0.5 ml and 3 mg/ml 7-AAD (Molecular Probes) was added.
Cell staining was assessed by a 5-color flow cytometer (FC500t with CXP software, Beckman Coulter) equipped with a 488 nm argon laser and standard band-pass filters (i.e. FL1 ¼ 525 nm for SYTO 16; FL2 ¼ 575 nm for PE; FL3 ¼ 620 nm for ECD; FL4 ¼ 675 nm for 7-AAD; FL5 ¼ 755 nm for PC7). Compensation was set before acquisition. Fluorescence signals were collected using logarithmic scales and light scatter signals were collected using linear scales. A gating protocol based on the International Society of Hematotherapy and Graft Engineering (ISHAGE) guidelines for CD34 þ cells 17 was used to select the 'nominally live' lymphocyte and CD34 þ cell populations and the gated populations were applied to 7-AAD/SYTO 16 density plots to determine cell viability status (see Figure 1 for details). The same 7-AAD/SYTO 16 quadrant positions set for the lymphocyte population were applied to the gated CD34 þ cell population run concurrently on the same CB-BC sample. Quadrant positioning to examine CD62L expression in conjunction with SYTO 16 staining was based on staining of the isotype-ECD negative control and the same SYTO 16 quadrant marker as used for the 7-AAD/SYTO 16 density plots for the gated lymphocytes and CD34 þ cells. CD62L histogram plots were also used to verify the correct placement of the quadrant marker (plots not shown). At least 100 000 lymphocyte events and 100 CD34 þ events were collected for each sample. All results shown are % values of the gated population.
Migration assay
Migration assays were performed in Costar transwell plates (Corning, Corning, NY, USA) containing 6.5 mm diameter, 5 mm pore-size membrane filter inserts. Briefly, 5 Â 10 5 cryopreserved-thawed CB leukocytes in 100 ml of phenol red-free Iscove's Modified Dulbecco's Medium (IMDM) (Gibco) supplemented with 0.5% HSA were placed in the upper compartment of the transwell plate and 0.6 ml of IMDM/0.5% HSA with 600 ng/ml stromal cellderived factor-1 (SDF-1) (Chemicon, Temecula, CA, USA) was placed in the lower compartment. Controls included wells without SDF-1 to determine spontaneous migration, and input cells without insert filters. Following incubation for 18 h at 371C in a humidified 5% CO 2 atmosphere, the migrated and non-migrated cells were collected and cell viability was determined by the SYTO 16/7-AAD assay as described above except that 1 Â 10 5 cells were stained with 1.5 nM of SYTO 16 in the presence of 30 mM verapamil and the flow cytometric gates shown in Figure 1 were increased to include apoptotic and necrotic lymphocytes and CD34 þ cells in the analysis.
Statistical analysis
Results shown are mean7standard error (s.e.). Differences between fresh and thawed CB samples, or migrated and The correct positioning of the quadrants could be verified by applying the gated CD45 þ /low SSC events (ie. gate C, f) onto a SYTO 16/7-AAD plot (plot not shown), as this population invariably contained additional necrotic SYTO 16 À /7-AAD þ events which were excluded in the final gate (i.e. gate D, g). At least 100 000 lymphocyte events and 100 CD34 þ events were collected for each sample.
non-migrated cells, were determined by two-tailed t-test for paired samples. The relationship between SYTO 16 staining intensity and CD62L expression was determined by regression analysis. All analyses were performed using Statgraphics Plus software (version 5; Manugistics Inc., Rockville, MD, USA). Significant difference was defined as P-value o0.05.
Results

SYTO 16 versus 7-AAD staining
The majority of lymphocytes and CD34 þ cells in fresh CB stained as SYTO 16 bright /7-AAD À cells, consistent with the staining profile of live cells, as shown in the SYTO 16/7-AAD flow cytometric density plots of a representative fresh CB-BC sample (Figure 2a and b, respectively) . In contrast, the paired thawed CB-BC sample showed the emergence of a subpopulation of SYTO 16 dim /7-AAD À lymphocytes ( Figure 2c ) and CD34 þ cells (Figure 2d ), which is consistent with the staining profile of apoptotic cells.
Analysis of 24 paired fresh and thawed CB-BC samples showed that SYTO 16 detected a significantly lower proportion of live lymphocytes compared to 7-AAD in fresh CB-BC samples (89711 and 10070.4% respectively; Po0.0001) and thawed CB-BC samples (55716 and 9775% respectively; Po0.0001) (Figure 2e ). SYTO 16 discriminated a significant population of SYTO 16 dim apoptotic lymphocytes in both fresh CB-BC samples and thawed CB-BC samples (11711 and 42714%, respectively) that were not evident by 7-AAD staining (Po0.0001 for both fresh and thawed CB-BC samples). Similar results were seen for CD34 þ cells (Figure 2f ), in that SYTO 16 detected a significantly lower proportion of live CD34 þ cells compared to 7-AAD in both fresh CB-BC samples (9278 and 9972% respectively; Po0.0001) and thawed CB-BC samples (78713 and 9872% respectively; Po0.0001) (Figure 2f) . A significant population of SYTO 16 dim apoptotic CD34 þ cells was identified in both fresh CB-BC samples and thawed CB-BC samples (777 and 20713%, respectively) that were not detected by 7-AAD staining (Po0.0001 for both fresh and thawed CB-BC samples).
The proportion of live SYTO 16 bright /7-AAD À cells in the paired fresh and thawed CB-BC samples (n ¼ 24 pairs) showed significant loss of viability of thawed lymphocytes (89711 and 55716%, respectively; Po0.0001) and thawed CD34 þ cells (9278 and 78713%, respectively; Po0.0001). The thawed lymphocyte population showed a significantly greater loss of viability compared to thawed CD34 þ cells (Po0.0001).
Migration and SYTO 16 staining
To show that SYTO 16 staining discriminates functionally competent cells, migration of CB leukocytes towards the chemoattractant SDF-1 was determined, followed by staining with SYTO 16. There were a significantly higher proportion of live SYTO 16 bright /7-AAD À lymphocytes and CD34 þ cells in the migrated cell population compared to the non-migrated population (P ¼ 0.0004 and 0.03, respectively) and conversely, a significantly lower proportion of SYTO 16 dim (apoptotic and necrotic) lymphocytes and CD34 þ cells in the migrated cell population compared to the non-migrated population (P ¼ 0.0004 and 0.03, respectively) ( Table 1) . Figure 3 shows the flow cytometric histograms of CD45 from a representative fresh CB-BC sample (Figure 3a) and the paired thawed sample (Figure 3b ). There was a significant decrease in the proportion of CD62L þ lymphocytes in thawed CB-BC samples compared to the paired fresh CB-BC samples (n ¼ 22 pairs) (1478 and 577 12% CD62L þ lymphocytes, respectively; Po0.0001) (Figure 3c ). Similar findings were observed for CD34 þ cells, with a significant decrease in the proportion of CD34 þ cells co-expressing CD62L in thawed CB-BC samples compared to the paired fresh CB-BC samples (n ¼ 22 pairs) (1479 and 48714% CD62L þ CD34 þ cells, respectively; Po0.0001) (Figure 4) .
CD62L expression
Regression analysis showed very strong positive correlations (r40.91, Po0.001) between the absence of CD62L expression and apoptotic SYTO 16 dim cells for fresh and thawed CB lymphocytes and CD34 þ cells (Table 2) . A positive correlation was also noted between the proportion of SYTO 16 bright lymphocytes and the proportion of SYTO 16 bright /CD62L À lymphocytes in thawed CB-BC samples (r ¼ 0.718; P ¼ 0.002) ( Table 2) . A similar, but weaker correlation was observed between SYTO 16 bright CD34 þ and SYTO 16 bright /CD62L À CD34 þ cells in thawed CB-BC samples (r ¼ 0.615; P ¼ 0.02). Such a relationship between live cells and absence of CD62L expression was not evident in fresh CB-BC samples suggesting that the loss of CD62L expression seen in thawed CB-BC samples is a consequence of cryopreservation-thawing.
Discussion
In this study, a significant proportion of apoptotic CD34 þ cells and lymphocytes were detected in cryopreservedthawed CB-BC by the SYTO 16 dye that were not detected by the 7-AAD viability dye. Fresh CB-BC samples had minimal apoptotic CD34 þ cells indicating that the emergence of apoptotic CD34 þ cells in thawed CB-BC samples was likely to be due to injury sustained from cryopreservation-thawing procedures. To our knowledge this is the first study to report the use of SYTO 16 for the detection of apoptotic CD34
þ cells in CB and the first to report the level of apoptotic cells in CB-BC samples that have been processed using procedures that replicated as closely as possible those used by Cord Blood Banks for the collection, processing, cryopreservation and thawing of CB. The results from our SDF-1 migration studies reported here, which showed a significantly higher proportion of live SYTO 16 bright CD34 þ cells and lymphocytes in the migrated cell population compared to the non-migrated population, provide further evidence that SYTO 16 staining intensity discriminates functionally competent, viable cells from apoptotic or damaged cells. 3, 6 Our findings suggest that methods that rely on cell impermeant dyes (e.g. 7-AAD) to assess cell viability significantly over-estimate the number of live CD34 þ cells and lymphocytes present in cryopreserved-thawed CB transplant products, as these dyes cannot distinguish apoptotic and live cells.
A significantly higher proportion of thawed CB CD34 þ cells stained as live SYTO 16 bright cells compared to the lymphocyte population, indicating that CD34 þ cells are more resilient to cryopreservation-induced injury. These findings are consistent with those reported by others for cryopreserved CB cells. 18, 19 Increased expression of antiapoptotic proteins (e.g. Bcl-2 and caspase-8 inhibitor FLIP) compared to pro-apoptotic proteins (e.g. Bax and activated caspases) by CD34 þ cells may provide an explanation, at least in part, to the differences seen in cryoinjury susceptibility between CD34 þ cells and lymphocytes. [19] [20] [21] The greater susceptibility of lymphocytes to cryoinjury is relevant in the context of multiple-unit CB transplants where long-term engraftment corresponds more closely to the CB unit with the highest CD3 þ cell dose rather than the CD34 þ cell content of the CB unit. 22 Accurate enumeration of live lymphocytes, in addition to enumeration of live CD34 þ cells, following thawing of CB products may become an important consideration for prediction of transplant outcome in multi-CB unit transplants.
We found that a significantly increased proportion of CD34 þ cells and lymphocytes did not express CD62L following thawing of CB-BC samples compared to the paired fresh CB-BC samples. Furthermore absence of CD62L expression was very strongly correlated with diminished SYTO 16 staining of both CD34 þ cells and lymphocytes. This suggests a direct relationship between loss of cell viability (i.e. induction of apoptosis) and loss of cell surface CD62L expression. To our knowledge, this is the first report of a direct relationship between apoptosis and absence of expression of CD62L on CD34 þ cells. Similar findings have been reported for T-cells induced to undergo apoptosis. 23 Other mechanisms, in addition to apoptosis induction, may also account for loss of CD62L expression by cryopreserved-thawed CB cells. Exposure of CD34 þ cells to DMSO (without cryopreservation) has been shown to result in significant loss of CD62L at the cell membrane. 9, 11 Induction of apoptosis was not determined in these previously reported studies, 9, 11 so cannot be excluded as a contributing factor to the observed loss of CD62L expression. Nevertheless, the positive correlation between live CD34 þ cells and absence of CD62L expression in thawed CB-BC samples reported here is indicative of CD62L shedding induced by the cryopreservation-thawing procedures. This conclusion is supported by our findings of no correlation between the expression or the absence of CD62L and the proportion of live SYTO 16 bright CD34 þ cells in fresh CB, which ordinarily contained sub-populations of live CD34 þ /CD62L þ cells and CD34 þ /CD62L À cells. Thus for live CD34 þ cells, cell-surface expression of CD62L does not appear to be associated with maintenance of viability. However, expression or absence of CD62L may distinguish functionality of CB CD34 þ cells. 9, 12 In conclusion, cryopreserved-thawed CB contains a significant proportion of apoptotic CD34 þ cells and lymphocytes that are not detected by current conventional viability dyes, such as 7-AAD. Our findings support the view of Schuurhuis et al. 3, 5, 6 that consideration needs to be given to the adoption of methods that simultaneously detect early apoptotic cells along with necrotic cells (i.e. the SYTO 16/7-AAD assay) for the accurate assessment of CD34 þ cell viability following thawing of cryopreserved HSC products, as this would provide a more accurate measure of the cells available to contribute to engraftment. Such methods will enable better-informed decisions regarding selection of CB units for transplantation and provide for a more accurate analysis of the relationship between grafted cell dose and recipient outcome. In addition, methods such as the SYTO 16/7-AAD assay provide an important tool to aid the development of new and improved procedures to maximize HSC product quality and efficacy.
